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1078–5Objective. We report our surgical treatment results of abdominal aortic aneurysm (AAA) in Behc¸et’s disease patient.
Materials and methods. Between September 1998 and June 2006, the authors have performed 21 procedures for AAA in
12 patients with Behc¸et’s disease. Male to female sex ratio was 3:1 and mean age was 34 years old. Behc¸et’s disease was
diagnosed clinically using criteria of International Study Group for Behc¸et’s Disease (1990). Retrospective analysis was
made.
Results. There were six infrarenal, five suprarenal, and one double (suprarenal and infrarenal)AAA. Six graft interposi-
tion, six patch closure, and one stent-graft insertion were performed (one graft interposition and one patch closure were
simultaneously performed for double AAA). Eight recurrent aneurysms were noted in six (50%) patients. Four stent-graft
insertion, two patch closures, one graft interposition and one explothoracotomy only were performed for recurrent aneu-
rysms. Overall recurrence rate of 21 procedures was 38.1%; 14.3% for graft interposition, 62.5% for patch closure, and
40% for stent-graft insertion.
Conclusion. Though the resection and graft interposition is technically difficult in many occasions, it should be considered
as the procedure of choice for abdominal aortic aneurysm in Behc¸et’s disease. Endovascular interventions may be one of the
treatment modality but the result needs further long-term follow-up.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Because of high rupture rate, aneurysm of Behc¸et’s
disease should be repaired. However, recurrent aneu-
rysm is frequently seen following surgical treatment.
Many attempts have been tried to prevent recurrence
including stent-graft treatment, but the recurrence or
puncture site aneurysm can be problematic.1e5 There
is still no definite medical treatment or widely ac-
cepted way of assessing disease activity.6e8
We have treated twelve Behc¸et’s disease patients with
abdominal aortic aneurysm by various treatment mo-
dalities and herein, report our surgical treatment results.sponding author. T.-W. Kwon, MD, PhD, Professor of Sur-
ivision of Vascular Surgery, Department of Surgery, Univer-
Ulsan College of Medicine and Asan Medical Center, 388-1
ap2-dong, Songpa-gu, Seoul 138-736, Korea.
address: twkwon2@amc.seoul.kr
884/000173 + 08 $34.00/0  2007 Published by Elsevier Ltd onMaterials and Methods
Between September 1998 and June 2006, the authors
have treated twelve patients with Behc¸et’s disease,
who had abdominal aortic aneurysm (AAA). Male
to female sex ratio was 3:1 and median age was 33.5
years old. The diagnosis of Behc¸et’s disease was
made clinically using criteria of International Study
Group for Behc¸et’s Disease (1990). Median follow-up
period was 45.5 (4e98) months.
Abdominal aortic aneurysm was diagnosed on ab-
dominopelvic CT (computerized tomographic) scan.
All patients were followed and monitored by one of
the authors (Bin Yu) regularly with one to three
months interval postoperatively. Parameters used for
the disease activity were relapsing symptoms,
CRP(C reactive protein) and ESR (Erythrocyte sedi-
mentation rate). As for imaging study, we used aortic
dissection CT scan regularly for 6 months interval fol-
lowing surgery. Retrospective analyses of the clinicalbehalf of European Society for Vascular Surgery.
174 T.-W. Kwon et al.manifestations, treatment modalities, and outcome on
these patients are reported.Results
The symptoms and signs of the patients that might be
clue in diagnosis of Behc¸et’s disease were recurrent
oral ulcer (100%), skin lesion (83.3%), recurrent genital
ulcer (50%), and positive Pathergy test (50%), and
eye lesion (33.3%), history of arterial surgery (25%),
deep vein thrombosis (25%), and arthritis (25%). The
elevation of erythrocyte sedimentation rate (ESR) or
C-reactive protein (CRP) was observed in all but one
patient (91.7%). Leukocytosis was noted in 8(66.7%).
Among the 12 patients, two patients (16.7%) devel-
oped abdominal aortic aneurysm while on immuno-
suppressive medication for Behc¸et’s disease and the
other ten patients came without diagnosis of Behc¸et’s
disease. As for previous arterial lesions, there were
three femoral artery aneurysms which had been
treated by resection and interposition graft using
prosthetic graft (Table 1).
All aneurysms were saccular in shape with median
40 mm of maximal diameter and median 15 mm of
neck diameter on preoperative CT scan (Fig. 1). In-
frarenal AAA was noted in 6 patients (50%) and su-
prarenal AAA was noted in 5 patients (41.7%). One
patient (8.3%) had suprarenal and infrarenal abdomi-
nal aortic aneurysms (Fig. 2). Contained rupture was
the most common manifestation of the aneurysm
and noted in nine out of 12 patients (75%), followed
by free rupture in 2 (16.7%), and occlusion of iliac ar-
tery in one patient (8.3%).
Because of urgency, all patients except one who
had AAA and iliac artery occlusion were treated on
emergency base. As for infrarenal AAA, four resection
and aorto-iliac graft interposition, one stent graft, andTable 1. Patient’s profile at the first presentation
Patient
N¼ 12
Sex Age Oral
ulcer
Skin
lesion
Genital
ulcer
Pathergy
test
Eye
lesi
1 M 38 Y Y þ
2 M 30 Y Y Y þ
3 M 50 Y Y  Y
4 F 16 Y Y Y 
5 M 44 Y Y  Y
6 M 35 Y Y þ
7 M 34 Y Y  Y
8 M 38 Y Y þ
9 F 26 Y Y Y e
10 M 31 Y þ Y
11 F 33 Y Y Y 
12 M 34 Y Y Y þ
M:F¼ 3:1 34* 100% 83.3% 50% 50% 33.3
DVT: Deep vein thrombosis; Y: Positive history; *: Mean age; V: Vein;
Eur J Vasc Endovasc Surg Vol 35, February 2008one patch closure were performed. As for suprarenal
AAA, four patch closure and one resection and graft
interposition with visceral artery reimplantation
were performed. In a patient with double AAA, patch
closure for suprarenal AAA and resection and aortoil-
iac graft interposition for infrarenal AAA were per-
formed simultaneously.
We have performed prosthetic wrapping on the
proximal aortic anastomotic site in every cases of graft
interposition to prevent anastomotic aneurysm. Omen-
tal wrapping was performed in recent two patients,
who had infrarenal AAA and double aneurysms.
Systemic immunosuppressive medication includ-
ing steroid, colchicines, azathioprine, or cyclophos-
phamide was given to all patients, postoperatively.
Dosage and combination of the medicine were indi-
vidually tailored.
There was no operative mortality. Mechanical ileus
during immediate postoperative period requiring op-
erative treatment occurred in two patients (16.7%).
Two patients died during the follow-up period. Rup-
tured recurrent aneurysm was the cause of death in
one patient four months after patch closure for su-
prarenal AAA and sepsis following necrotizing fas-
ciatis was the cause of death in other patient at 21
months after graft interposition for infrarenal AAA.
Recurrent aneurysm was noted in six (50%) patients.
As for location of aneurysm, there were two recur-
rences out of seven (28.6%) infrarenal AAA and
four recurrences out of six (66.7%) suprarenal AAA.
Regarding the procedures, there was one recurrence
out of six interposition graft (16.7%), four out of six
patch closures (66.7%), and one stent graft insertion
(100%).
There were 8 recurrences in 6 patients. Each patient
had one recurrence except one who had multiple re-
currences (three times). Median recurrence interval
was 19(4e98) months.on
DVT Arterial
disease
Arthritis Prior immuno
suppressant
Iliac V
Iliac V
Iliac V FA
FA Y
Y
Y
FA Y Y
% 25% 25% 25% 16.7%
FA: Previous femoral artery aneurysm.
Fig. 1. Typical feature of AAA (white circles) in Behc¸et’s disease - saccular in shape with relatively short neck portion. Three
dimensional reconstruction (A), sagital section (B), and axial section (C) on CT scan.
Fig. 2. Double AAA in Behc¸et’s disease on CT scan; One is
suprarenal (white circle) and the other is infrarenal (black
circle).
175Surgical Treatment Result of Abdominal Aortic AneurysmTreatment for the eight recurrent lesions were four
stent graft insertion (Figs. 3e5), two patch closure, one
graft interposition and visceral artery reimplantation,
and one explothoracotomy only. One patient who had
three recurrences had been treated with redo patch
closure for the first recurrence, stent graft treatment
for the second recurrence, and interposition graft
with visceral artery reimplantation for the third recur-
rence (Table 2).
Overall recurrence rate by the procedure (21 proce-
dures) was 38.1%. Recurrence rate of the resection
with interposition graft, patch closure, and stent-graft
insertion were 14.3% (1/7), 62.5% (5/8) and 40% (2/5),
respectively (Table 3).
There were no significant statistical differences in
recurrence rate between sex, age, and clinical manifes-
tation, location of the aneurysm, ESR, CRP and post-
operative immunosuppressive medication. However,
those with interposition showed less recurrence than
patch ( p¼ 0.0389) with statistical significance and
showed the best result among the three procedures
(Fig. 6).Discussion
Behc¸et’s disease is a chronic recurrent inflammatory
disorder affecting many organs. Patients are usually
20e30 years old at the time of onset of the disease.9Eur J Vasc Endovasc Surg Vol 35, February 2008
Fig. 3. Recurrent aneurysm (white circle) at distal anastomosis site of aortic graft (A) and stent graft treatment (B).
176 T.-W. Kwon et al.The clinical course of Behc¸et’s disease is character-
ized by remissions and exacerbations that generally
abate in intensity with the passage of time. There is
no universally accepted diagnostic test or accepted
way of assessing disease activity.6,7 Thus, the diagno-
sis of Behc¸et’s disease has relied on identification of
several of its more typical clinical features. At present,
the diagnosis is made on the basis of the criteria pro-
posed by the International Study Group for Behc¸et’s
Disease in 1990.10
The spectrum of vascular disease is broad and
unique in Behc¸et’s disease. It is one of the few vasculitis
that can involve large vessels, both arteries and veins.
The frequency of vascular involvement in Behc¸et’s
disease is estimated 2 to 46% and it is four to five
times more common in men in endemic region.1,11e15
Vascular lesions seen in Behc¸et’s disease are venous
thrombosis, arterial thrombosis, and arterial aneu-
rysm. Inflammation of the aorta, pulmonary andFig. 4. Recurrent aneurysm (white circle) at aortic pat
Eur J Vasc Endovasc Surg Vol 35, February 2008peripheral arteries is one of the most serious compli-
cations of Behc¸et’s disease and is responsible for the
majority of deaths.9,16 Arterial lesions are less com-
mon than venous disease and its prevalence is about
1.5 to 3% worldwide. Aneurysm is reported to be
more common than occlusion and aneurysm forma-
tion is seen in almost all named arteries but the ab-
dominal aorta is the most common site. Rupture is
the most common complication of aneurysm and the
most common cause of vascular related death.2,9,13,17
Multiple aneurysms are relatively common.18,19
Exact incidence of arterial lesion or aneurysm in
Behc¸et’s disease in Korea is not known. In our small
series, aneurysm was more common than occlusion,
and most commonly seen was the abdominal aortic
aneurysm. Aneurysm in Behc¸et’s disease is different
from that of degenerative type in many aspects. The
age incidence is younger, suprarenal type is more
commonly seen, shape of aneurysm is usuallych closure site (A, B) and stent graft treatment (C).
Fig. 5. Recurrent aneurysm (white circle) at distal portion of aortic stent graft (A, B) and stent graft treatment (C).
177Surgical Treatment Result of Abdominal Aortic Aneurysmsaccular, multiple aneurysm is more frequently seen,
and symptom is more urgent.
Of all the vascular lesions in Behc¸et’s disease, aneu-
rysm is the most complicated and challenging pathol-
ogy for the vascular surgeon because of the technical
difficulties and frequent recurrence.20e23
Since the first report of an abdominal aortic aneu-
rysm due to Behc¸et’s disease, by Mishima24 in 1961,
many attempts have been made to surgically manage
these serious arterial lesions. However, these were
a case report or experience with small numbers of
patients.
Some authors insisted that the establishment of re-
mission by use of glucocorticoid before the surgical
intervention can decreases the incidence of post-
operative anastomotic complications.25 Because of ur-
gency, we performed surgery on emergency base so
we could not use preoperative steroid. Two patients
in our series developed abdominal aortic aneurysm
while on immunosuppressive medication for Behc¸et’s
disease. It has been reported that rupture is not corre-
lated to the size of aneurysm in Behc¸et’s disease26 and
aneurysm should be repaired at the time of detection
because of high rupture risk. This is true in our series
that all aneurysms were saccular in shape with me-
dian 40 mm of maximal diameter relatively short
neck and contained rupture was the most common in-
dication for treatment.
Some authors have suggested performing a bypass
with anastomoses on ‘‘intact’’ arteries, far away from
the aneurysms, or performing an extraanatomic by-
pass.27,28 Others suggested simple aneurysmectomy
or closure of the arterial defect by direct suture orpatching.3 Actually, we performed patch closure
mainly in suprarenal AAA because of urgency and
technical difficulties while we performed resection
and interposition graft mainly in infrarenal AAA. So
it’s not easy to compare these two procedures but
patch closure showed statistically significant higher
recurrence rate than resection and interposition graft
in our series. Performing a bypass with anastomoses
on ‘‘intact’’ arteries seems to be as the procedure of
choice for abdominal aortic aneurysm in Behc¸et’s dis-
ease. Arterial protection by prosthetic wrapping has
been reported.3 We have also performed prosthetic
wrapping on the proximal aortic anastomotic site
which seemed to be effective in preventing recur-
rence. But considering iliac anastomotic site which
was not wrapped, we could not evaluate the exact
role of this prosthetic wrapping. Recently, we have
performed omental wrapping over the graft or patch
after resection of the aneurysm as Tu¨zu¨n reported.2
Above is not an evidence based procedure but it
may be helpful in decreasing the dead space and alle-
viating the residual inflammation following resection
of the aneurysm.
Recently, stent graft treatment has been reported as
one of the treatment modality for an aneurysm to
avoid a recurrent aneurysm at the anastomosis site
which was commonly seen following surgical
treatment.26,29,30
We have performed five stent graft treatments (one
for original lesion and four for recurrent aneurysms).
Stent grafts used were custom-made S & G straight
stent grafts with proximal and distal bare stents for
fixation. All stent grafts were deployed through 14Eur J Vasc Endovasc Surg Vol 35, February 2008
Table 2. Characteristics of lesion, treatment and result
Patient Location
of AAA
Size Symptom Treatment
(graft size:
mm & type)
Compli-
cation
Immuno-
suppresant
Recurr-
ence
Follow
Up
duration
Result
Maximal
diameter (mm)
Neck
diameter (mm)
1 Infra 40 15 C. Rupture Interposition(PTFE) Ileus PdþCol 98 M Alive
16 8, bifurcated
2 Infra 50 20 C. Rupture Interposition(PTFE) PdþCol 21 M Death
16 8, bifurcated
3 Infra 60 20 Occlusion Interposition(PTFE) PdþColþAza 66 M Alive
14, straight
4 Infra 35 10 C. Rupture Interposition(PTFE) PdþCol 13 M Alive
14 7, bifurcated
5 Supra 70 10 F. Rupture Patch(PTFE) PdþCyc 48 M Alive
6 Supra 25 15 C. Rupture Patch(PTFE) PdþCol 4 M Alive
6 (Double) Infra 30 15 Interposition(PTFE)
18 9, bifurcated
7 Supra 50 50 C. Rupture Interposition(Dacron)* PdþColþAza 18 M 92 M Alive
16, straight
7 (R) Distal anast. Recurrent Stent graft PdþColþAza
18, straight
8 Infra 35 20 C. Rupture Patch(PTFE) PdþCol 11 M 31 M Alive
8 (R) Patch site Recurrent Stent graft PdþColþCyc
18, straight
9 Supra 50 10 C. Rupture Patch(PTFE) PdþColþAza 8 M 73 M Alive
9 (R) Patch site Recurrent Patch(PTFE) PdþColþAza 17 M
9 (R) Patch site Recurrent Stent graft PdþColþCyc 32 M
20, straight
9 (R) Stent graft distal Recurrent Interposition(PTFE)* PdþColþCyc
22, straight
10 Supra 50 15 Rupture Patch(PTFE) Ileus ColþAza 18 M 43 M Alive
10 (R) Patch site Recurrent Patch(PTFE) PdþAza
11 Supra 25 10 C. Rupture Patch (Dacron) PdþCyc 5 M 4 M Death
11 (R) Patch site Recurrent Explothoracotomy Op death
12 Infra 35 20 C. Rupture Stent graft PdþColþAza 19 M 52 M Alive
18, straight
12 (R) Stent graft proximal Recurrent Stent graft PdþColþAza
22, straight
Total 21 Median
40 mm
Median
15 mm
Median
45.4 M
Supra: Suprarenal; Infra: Infrarenal; (R): Recurrent; *: Graft interposition with visceral artery reimplantation; M: Months; Anast: anastomosis; C.: Contatined; F.: Free; Pd: Prednisolone;
Aza: Azathioprine; Col: Colchicines; Cyc: Cyclophosphamide.
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Table 3. Recurrence rate according to the procedure or location of the aneurysm
Graft interposition Patch closure Stent graft Explothoracotomy Recurrence rate (%)
Suprarenal AAA 1/1 3/5 4/6 (66.7)
Infrarenal AAA 0/5 1/1 1/1 2/7 (28.6)
Recurrent aneurysm 0/1 1/2 1/4 0/1 2/8 (25)
Recurrence rate (%) 1/7 (14.3) 5/8 (62.5) 2/5 (40) 0/1 8/21 (38.1)
179Surgical Treatment Result of Abdominal Aortic AneurysmFrench sheath which was introduced via one femoral
puncture.Femoral puncture sites were managed by
manual compression. There was no initial or late en-
doleak and there was no early or late puncture site
problem. However, recurrent aneurysms occurred at
the site just proximal or distal to stent graft in two pa-
tients where the aorta was thought to be normal pre-
viously, were noted (40% of recurrence rate). No
femoral pseudoaneurysm developed at the puncture
site during the follow-up period. The main advan-
tages of endovascular intervention are low mortality
rates (0.6%e3.5%) and high technical immediate suc-
cess rates.31 However, experience with the endovascu-
lar treatment is still limited in Behc¸et’s disease patient.
Furthermore, one of the most important aspects of
Behc¸et’s disease is aneurysmal arteriopathy and its
tendency to develop recurrent false aneurysm at an-
giographic puncture site.1e5 Though there was no
puncture site aneurysm in our series, it should be per-
formed in selected cases with caution.32
Some authors supported a surgical approach with
simple ligature of the artery to avoid complications
of reconstructive surgery in peripheral arterial le-
sions.2 It seemed to be true especially for aneurysm
at superficial femoral artery. In our series, there
were three femoral artery aneurysms that had been
treated by resection and prosthetic graft interposition
but all subsequently occluded without symptom of
critical limb ischemia.Fig. 6. Recurrence rates of the three procedures.Immunosuppressant and anti-inflammatory medi-
cation should be conducted for suppression of the
vasculitis.7 However, the role of immunosuppressant
and anti-inflammatory medication for prevention of
the recurrent arterial lesion following intervention in
Behc¸et’s disease also needs to be further evaluated.
In conclusion, resection and interposition graft
showed much better result than patch closure for
AAA due to Behc¸et’s disease with statistical signifi-
cance in our series. Though the resection and graft in-
terposition is technically difficult in many occasions, it
should be considered as the procedure of choice for
abdominal aortic aneurysm in Behc¸et’s disease. Endo-
vascular interventions may be one of the treatment
modality but the result needs further long-term fol-
low-up. Because of high recurrence rate and lack of
specific tool for early diagnosis of recurrence, at pres-
ent, close follow-up with regular interval is the only
way to be recommended for detection and treatment
of recurrent AAA in patients with Behc¸et’s disease.References
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